The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone302-773-1000
Debt
Debt-to-Equity Ratio4.13
Current Ratio2.21
Quick Ratio1.60
Price-To-Earnings
Trailing P/E Ratio12.20
Forward P/E Ratio8.19
P/E Growth0.53
Sales & Book Value
Annual Sales$6.18 billion
Price / Sales1.34
Cash Flow$5.4135 per share
Price / Cash8.61
Book Value$4.67 per share
Price / Book9.98
Profitability
EPS (Most Recent Fiscal Year)$3.82
Net Income$746 million
Net Margins13.79%
Return on Equity107.89%
Return on Assets12.09%
Miscellaneous
Employees7,000
Outstanding Shares177,910,000
Chemours (NYSE:CC) Frequently Asked Questions
What is Chemours' stock symbol?
Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."
How often does Chemours pay dividends? What is the dividend yield for Chemours?
Chemours declared a quarterly dividend on Tuesday, May 1st. Investors of record on Thursday, May 17th will be paid a dividend of $0.17 per share on Friday, June 15th. This represents a $0.68 annualized dividend and a dividend yield of 1.46%. The ex-dividend date of this dividend is Wednesday, May 16th. View Chemours' Dividend History.
How will Chemours' stock buyback program work?
Chemours declared that its Board of Directors has authorized a share buyback plan on Monday, December 4th 2017, which allows the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.
How were Chemours' earnings last quarter?
Chemours Co (NYSE:CC) issued its earnings results on Thursday, May, 3rd. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.22 by $0.19. The specialty chemicals company earned $1.73 billion during the quarter, compared to analyst estimates of $1.65 billion. Chemours had a net margin of 13.79% and a return on equity of 107.89%. Chemours's revenue was up 20.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 EPS. View Chemours' Earnings History.
When is Chemours' next earnings date?
What price target have analysts set for CC?
10 equities research analysts have issued 1 year price objectives for Chemours' stock. Their predictions range from $55.00 to $69.00. On average, they anticipate Chemours' stock price to reach $60.9444 in the next twelve months. View Analyst Ratings for Chemours.
Who are some of Chemours' key competitors?
Some companies that are related to Chemours include DSM (RDSMY), ASAHI KASEI Cor/ADR (AHKSY), FMC (FMC), JOHNSON MATTHEY/S (JMPLY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), Innospec (IOSP) and KMG Chemicals (KMG).
Who are Chemours' key executives?
Chemours' management team includes the folowing people:
- Mr. Mark P. Vergnano, Pres, CEO & Director (Age 60)
- Mr. Mark E. Newman, Sr. VP & CFO (Age 55)
- Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
- Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 61)
- Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 54)
Has Chemours been receiving favorable news coverage?
Media headlines about CC stock have been trending somewhat positive on Thursday, Accern Sentiment reports. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Chemours earned a news impact score of 0.24 on Accern's scale. They also gave headlines about the specialty chemicals company an impact score of 47.95 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Chemours' major shareholders?
Chemours' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.88%), Iridian Asset Management LLC CT (2.56%), Prudential Financial Inc. (2.16%), Allianz Asset Management GmbH (1.39%), Allianz Asset Management GmbH (1.39%) and Northern Trust Corp (0.96%). Company insiders that own Chemours stock include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Paul Kirsch and Richard H Brown. View Institutional Ownership Trends for Chemours.
Which major investors are selling Chemours stock?
CC stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Natixis, Hsbc Holdings PLC, JPMorgan Chase & Co., Spark Investment Management LLC, Caisse DE Depot ET Placement DU Quebec, Thrivent Financial for Lutherans and Swiss National Bank. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for Chemours.
Which major investors are buying Chemours stock?
CC stock was bought by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, First Eagle Investment Management LLC, Point72 Asset Management L.P., Millennium Management LLC, Scopus Asset Management L.P., Carillon Tower Advisers Inc., Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for Chemours.
How do I buy shares of Chemours?
Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemours' stock price today?
One share of CC stock can currently be purchased for approximately $46.61.
How big of a company is Chemours?
Chemours has a market capitalization of $8.40 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.82 on an earnings per share basis. Chemours employs 7,000 workers across the globe.
How can I contact Chemours?
Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]
MarketBeat Community Rating for Chemours (CC)
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
